Pfizer secures 4th cancer drug approval in 2 months

Pfizer secures 4th cancer drug approval in 2 months

Immunocore and Genentech Dig into Immuno-Oncology in Solid Tumors With Expanded Research Deal

Immunocore and Genentech Dig into Immuno-Oncology in Solid Tumors With Expanded Research Deal

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years

Science behind Nobel winners spawned one of the biggest marketing duels in pharma history

Science behind Nobel winners spawned one of the biggest marketing duels in pharma history